201 related articles for article (PubMed ID: 34915408)
1. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG;
Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
3. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality.
Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707
[TBL] [Abstract][Full Text] [Related]
4. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
[TBL] [Abstract][Full Text] [Related]
5. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.
Kortlever TL; de Jonge L; Wisse PHA; Seriese I; Otto-Terlouw P; van Leerdam ME; Spaander MCW; Dekker E; Lansdorp-Vogelaar I
Prev Med; 2021 Oct; 151():106643. PubMed ID: 34217421
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
8. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
[TBL] [Abstract][Full Text] [Related]
9. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands.
Breekveldt ECH; Toes-Zoutendijk E; Spaander MCW; van de Schootbrugge-Vandermeer HJ; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
Eur J Cancer; 2023 Jan; 178():60-67. PubMed ID: 36403368
[TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
[TBL] [Abstract][Full Text] [Related]
11. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
[TBL] [Abstract][Full Text] [Related]
12. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
[TBL] [Abstract][Full Text] [Related]
13. Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020.
Meijer J; Elferink MAG; Vink GR; Sijtsma FPC; Buijsen J; Nagtegaal ID; Tanis PJ; Wumkes ML; de Hingh IHJT; Siesling S;
Int J Colorectal Dis; 2022 Sep; 37(9):2013-2020. PubMed ID: 35986108
[TBL] [Abstract][Full Text] [Related]
14. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan.
Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T
JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
Larsen MB; Njor S; Ingeholm P; Andersen B
Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
[TBL] [Abstract][Full Text] [Related]
17. The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic.
Losurdo P; Samardzic N; Di Lenarda F; de Manzini N; Giudici F; Bortul M
Updates Surg; 2022 Jun; 74(3):1063-1072. PubMed ID: 34978052
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection Waves.
Derksen JWG; May AM; van de Poll-Franse LV; de Rooij BH; Hafkenscheid DA; Verkooijen HM; Koopman M; Vink GR
JNCI Cancer Spectr; 2021 Aug; 5(4):pkab047. PubMed ID: 34373848
[TBL] [Abstract][Full Text] [Related]
20. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
